FULL TECHNICAL AND REGULATORY SUPPORT

DAPAGLIFLOZIN (CAS 461432-26-8), also known as FORXIGA^® and FARXIGA^®, is a prescription medication used to control blood sugar levels in people with type-2 diabetes. Dapagliflozin works in the kidney to block a protein called SGLT2, which is in charge of delivering glucose into the bloodstream.

THERAPEUTIC INDICATION: ANTI-DIABETES

DAPAGLIFLOZIN is used for the treatment of type-2 diabetes. It is taken as film-coated tablets of 10mg.

MARKET INFORMATION

Originator: BRISTOL-MYERS SQUIBB in partnership with ASTRA ZENECA

Trade names: FORXIGA^®, FARXIGA^®

YOUR ADVANTAGES

Reliable supply guaranteed
Short lead time with full technical and regulatory support

^{This article uses material from Wikipedia, which is released under the Creative Commons Attribution-Share-Alike License 3.0.}